Xwell (XWEL) Net Income towards Common Stockholders Growth (3y) (2013 - 2026)
Xwell (XWEL) Net Income towards Common Stockholders Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.89% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | -7.69% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 14.70% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 3.93% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -6.41% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | 14.66% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | 42.35% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 2.87% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 10.22% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | -26.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.60% |
| Dec 31, 2025 | -8.21% |
| Sep 30, 2025 | 41.02% |
| Jun 30, 2025 | 27.34% |
| Mar 31, 2025 | -24.16% |
| Dec 31, 2024 | -113.81% |
| Sep 30, 2024 | -41.76% |
| Jun 30, 2024 | 24.99% |
| Mar 31, 2024 | -45.95% |
| Dec 31, 2023 | 29.54% |
| Sep 30, 2023 | -20.18% |
| Jun 30, 2023 | 53.90% |
| Mar 31, 2023 | 19.91% |
| Jun 30, 2021 | -110.10% |
| Mar 31, 2021 | -10.12% |
| Dec 31, 2020 | -21.55% |
| Sep 30, 2020 | -111.82% |
| Jun 30, 2020 | -194.17% |
| Mar 31, 2020 | -93.59% |
| Dec 31, 2017 | -216.39% |